Sort by
Refine Your Search
-
closely with Dr Ija Trapeznikova , Dr Ahu Gemici and Prof Juan Pablo Rud . As part of the research team, the RA will work on cleaning, standardising and organising secondary data for a number of developing
-
documentation, supporting partners in protocol development and laboratory set up and training before and during the clinical trials. The post-holder will also be expected to contribute to ad-hoc activities
-
return we offer a highly competitive rewards and benefits package including: Generous annual leave entitlement Training and Development opportunities Pension Scheme with generous employer contribution
-
vaccination barriers and facilitators, develop forecasts of vaccine coverage for existing and novel vaccines (e.g. HPV, RSV, malaria), and support the design and implementation of small area estimation and
-
of pediatric brain tumours (Vinel et al BMC Biology 2025, Constantinou et al Cell Reports 2024 and Vinel et al. Nature Communications 2021) to develop new personalised therapies. About You We seek an ambitious
-
, and OpenSAFELY, and to develop and apply the new generation of analytical methods to study environmental health risks and climate change. The post will provide opportunities for interactions with
-
2025. We seek to recruit a Research Associate specialising in statistical modelling and machine learning to join our multi-university multi-disciplinary team developing a groundbreaking technique based
-
at the Barts Cancer Institute (Queen Mary University of London). This role will involve analysing existing spatial-omics data sets and developing novel computational tools to understand the risk of developing
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving
-
will have a PhD in a related field, an emerging track record of outstanding publications, and well-developed plans for new research projects. This post is generously funded by the A. G. Leventis